---
title: "MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282051269.md"
description: "MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial"
datetime: "2026-04-08T13:39:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282051269.md)
  - [en](https://longbridge.com/en/news/282051269.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282051269.md)
---

# MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial

MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial

### Related Stocks

- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [MAIA.US](https://longbridge.com/en/quote/MAIA.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [MAIA Biotechnology to Terminate ATM Agreement With H.C. Wainwright After Raising $5.68M](https://longbridge.com/en/news/286468852.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference](https://longbridge.com/en/news/286652404.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Guardant Health Says US FDA Approved Liquid Biopsy Test](https://longbridge.com/en/news/287069625.md)